SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$0.31
-0.02 (-5.86%)
As of Sep 28, 10:36 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +945.2% upside
Low Target $1.82
Average Target $3.24
High Target $4.40
Current Price $0.31
Current
$0.31
Target
$3.24
$1.82 $3.24 avg $4.40
Scenario Analysis
Bear Case
$1.82
487.1%
Low target
Base Case
$3.24
+945.2%
Avg target
Bull Case
$4.40
+1,319.4%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$2.88
-89.2% from high
52-Week Low
$0.29
+6.9% from low
Target vs 52W High
$3.24
+12.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%